Cytek Biosciences Stock Price History
CTKB Stock | USD 5.13 0.09 1.72% |
If you're considering investing in Cytek Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cytek Biosciences stands at 5.13, as last reported on the 25th of February, with the highest price reaching 5.28 and the lowest price hitting 5.00 during the day. Cytek Biosciences secures Sharpe Ratio (or Efficiency) of -0.0814, which signifies that the company had a -0.0814 % return per unit of risk over the last 3 months. Cytek Biosciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cytek Biosciences' Mean Deviation of 2.6, standard deviation of 4.16, and Risk Adjusted Performance of (0.05) to double-check the risk estimate we provide.
Cytek Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Cytek |
Sharpe Ratio = -0.0814
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | CTKB |
Estimated Market Risk
4.16 actual daily | 37 63% of assets are more volatile |
Expected Return
-0.34 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cytek Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cytek Biosciences by adding Cytek Biosciences to a well-diversified portfolio.
Cytek Biosciences Stock Price History Chart
There are several ways to analyze Cytek Stock price data. The simplest method is using a basic Cytek candlestick price chart, which shows Cytek Biosciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | January 14, 2025 | 7.26 |
Lowest Price | February 21, 2025 | 5.12 |
Cytek Biosciences February 25, 2025 Stock Price Synopsis
Various analyses of Cytek Biosciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cytek Stock. It can be used to describe the percentage change in the price of Cytek Biosciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cytek Stock.Cytek Biosciences Price Rate Of Daily Change | 0.98 | |
Cytek Biosciences Price Action Indicator | (0.06) | |
Cytek Biosciences Price Daily Balance Of Power | (0.32) | |
Cytek Biosciences Accumulation Distribution | 41,281 |
Cytek Biosciences February 25, 2025 Stock Price Analysis
Cytek Stock Price History Data
The price series of Cytek Biosciences for the period between Wed, Nov 27, 2024 and Tue, Feb 25, 2025 has a statistical range of 2.22 with a coefficient of variation of 10.56. The prices are distributed with arithmetic mean of 6.06. The median price for the last 90 days is 6.21.Open | High | Low | Close | Volume | ||
02/25/2025 | 5.23 | 5.28 | 5.00 | 5.13 | 778,433 | |
02/24/2025 | 5.12 | 5.28 | 5.12 | 5.22 | 535,213 | |
02/21/2025 | 5.31 | 5.36 | 5.11 | 5.12 | 552,810 | |
02/20/2025 | 5.35 | 5.37 | 5.19 | 5.20 | 381,798 | |
02/19/2025 | 5.27 | 5.41 | 5.18 | 5.36 | 469,830 | |
02/18/2025 | 5.23 | 5.42 | 5.21 | 5.31 | 653,353 | |
02/14/2025 | 5.28 | 5.48 | 5.18 | 5.23 | 570,977 | |
02/13/2025 | 5.25 | 5.36 | 5.17 | 5.22 | 737,266 | |
02/12/2025 | 5.16 | 5.29 | 5.16 | 5.20 | 687,445 | |
02/11/2025 | 5.08 | 5.22 | 4.90 | 5.20 | 2,684,327 | |
02/10/2025 | 5.33 | 5.40 | 5.13 | 5.15 | 668,162 | |
02/07/2025 | 5.59 | 5.69 | 5.25 | 5.34 | 512,777 | |
02/06/2025 | 5.66 | 5.68 | 5.51 | 5.61 | 737,540 | |
02/05/2025 | 5.46 | 5.66 | 5.41 | 5.61 | 784,662 | |
02/04/2025 | 5.33 | 5.43 | 5.14 | 5.42 | 893,004 | |
02/03/2025 | 5.05 | 5.56 | 5.03 | 5.39 | 908,009 | |
01/31/2025 | 5.08 | 5.40 | 4.90 | 5.15 | 945,218 | |
01/30/2025 | 5.73 | 5.84 | 5.62 | 5.66 | 433,523 | |
01/29/2025 | 5.94 | 5.94 | 5.59 | 5.69 | 742,418 | |
01/28/2025 | 5.76 | 6.01 | 5.72 | 6.00 | 579,831 | |
01/27/2025 | 5.75 | 5.89 | 5.56 | 5.73 | 743,293 | |
01/24/2025 | 5.66 | 5.82 | 5.65 | 5.74 | 525,151 | |
01/23/2025 | 5.71 | 5.78 | 5.54 | 5.69 | 596,034 | |
01/22/2025 | 5.81 | 5.99 | 5.73 | 5.77 | 753,226 | |
01/21/2025 | 5.54 | 5.89 | 5.51 | 5.88 | 940,677 | |
01/17/2025 | 5.56 | 5.60 | 5.37 | 5.46 | 705,636 | |
01/16/2025 | 5.70 | 5.84 | 5.38 | 5.49 | 1,230,384 | |
01/15/2025 | 6.87 | 6.93 | 5.62 | 5.68 | 1,525,322 | |
01/14/2025 | 7.25 | 7.30 | 7.08 | 7.26 | 1,356,823 | |
01/13/2025 | 6.72 | 7.29 | 6.72 | 7.21 | 1,381,105 | |
01/10/2025 | 6.63 | 6.88 | 6.54 | 6.82 | 695,237 | |
01/08/2025 | 6.85 | 6.89 | 6.64 | 6.83 | 540,034 | |
01/07/2025 | 6.73 | 7.00 | 6.73 | 6.89 | 754,878 | |
01/06/2025 | 6.89 | 6.91 | 6.76 | 6.79 | 520,450 | |
01/03/2025 | 6.60 | 6.90 | 6.56 | 6.83 | 673,246 | |
01/02/2025 | 6.58 | 6.85 | 6.46 | 6.57 | 480,797 | |
12/31/2024 | 6.58 | 6.68 | 6.46 | 6.49 | 273,543 | |
12/30/2024 | 6.49 | 6.83 | 6.41 | 6.55 | 476,364 | |
12/27/2024 | 6.53 | 6.62 | 6.26 | 6.39 | 258,365 | |
12/26/2024 | 6.42 | 6.57 | 6.36 | 6.53 | 327,088 | |
12/24/2024 | 6.50 | 6.55 | 6.36 | 6.49 | 208,988 | |
12/23/2024 | 6.27 | 6.53 | 6.27 | 6.46 | 360,115 | |
12/20/2024 | 6.04 | 6.39 | 6.04 | 6.32 | 2,028,591 | |
12/19/2024 | 6.43 | 6.52 | 6.06 | 6.19 | 654,711 | |
12/18/2024 | 6.51 | 6.78 | 6.14 | 6.24 | 716,063 | |
12/17/2024 | 6.52 | 6.59 | 6.37 | 6.43 | 504,599 | |
12/16/2024 | 6.19 | 6.58 | 6.19 | 6.58 | 592,023 | |
12/13/2024 | 6.43 | 6.43 | 6.11 | 6.21 | 537,173 | |
12/12/2024 | 6.51 | 6.60 | 6.41 | 6.47 | 428,820 | |
12/11/2024 | 6.76 | 6.77 | 6.46 | 6.56 | 418,142 | |
12/10/2024 | 6.83 | 6.89 | 6.63 | 6.73 | 638,572 | |
12/09/2024 | 6.49 | 6.88 | 6.47 | 6.80 | 803,336 | |
12/06/2024 | 6.61 | 6.85 | 6.42 | 6.47 | 435,380 | |
12/05/2024 | 6.65 | 6.77 | 6.52 | 6.54 | 465,553 | |
12/04/2024 | 6.68 | 6.81 | 6.52 | 6.69 | 691,570 | |
12/03/2024 | 6.88 | 6.90 | 6.62 | 6.71 | 523,961 | |
12/02/2024 | 6.50 | 6.93 | 6.37 | 6.92 | 635,229 | |
11/29/2024 | 6.54 | 6.61 | 6.46 | 6.53 | 519,326 | |
11/27/2024 | 6.49 | 6.56 | 6.40 | 6.50 | 575,728 | |
11/26/2024 | 6.60 | 6.63 | 6.29 | 6.41 | 668,829 | |
11/25/2024 | 6.68 | 6.83 | 6.51 | 6.69 | 602,329 |
About Cytek Biosciences Stock history
Cytek Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cytek is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cytek Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cytek Biosciences stock prices may prove useful in developing a viable investing in Cytek Biosciences
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California. Cytek Biosciences operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 555 people.
Cytek Biosciences Stock Technical Analysis
Cytek Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
All Next | Launch Module |
Cytek Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cytek Biosciences' price direction in advance. Along with the technical and fundamental analysis of Cytek Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cytek to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.05) | |||
Jensen Alpha | (0.35) | |||
Total Risk Alpha | (0.38) | |||
Treynor Ratio | 1.19 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Cytek Stock analysis
When running Cytek Biosciences' price analysis, check to measure Cytek Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytek Biosciences is operating at the current time. Most of Cytek Biosciences' value examination focuses on studying past and present price action to predict the probability of Cytek Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytek Biosciences' price. Additionally, you may evaluate how the addition of Cytek Biosciences to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |